Riskpilot← Back to searchSign inGet full accessØJENLÆGE JAN MØRKENBORG ApS
APSActiveCVR 31501385Havborgvej 8, 1.Medical specialists activities · NACE 8622Est. 20085 employees
Revenue 2025
DKK 5,7M
+1% vs 2024
EBITDA margin
58.1%
+4% vs 2024
Equity ratio
59.5%
Financial strength
Net profit 2025
DKK 2,6M
+5% vs 2024
| Revenue | DKK 5,7M | +1% |
| EBITDA | DKK 3,3M | +4% |
| Net profit | DKK 2,6M | +5% |
| Total assets | DKK 5,5M | +13% |
| Equity | DKK 3,3M | +3% |
| Employees | 5 | — |
Legal name
ØJENLÆGE JAN MØRKENBORG ApS
CVR number
31501385
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
25. juni 2008
Share capital
DKK 125.000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktion.
Company purpose
Selskabets formål er at udføre øjenlægevirksomhed samt hermed relateret virksomhed.
Address
Havborgvej 8, 1.
Phone
+4575120177
Email
Langlihuset@protonmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5.199 | 5.457 | 5.767 | 5.667 | 5.704 |
| Staff expenses | -1.872 | -2.067 | -2.377 | -2.468 | -2.392 |
| EBITDA | 3.327 | 3.390 | 3.390 | 3.199 | 3.312 |
| Depreciation & amort. | -167 | -107 | -82 | -58 | -18 |
| EBIT | 3.160 | 3.282 | 3.307 | 3.142 | 3.294 |
| Net financials | 103 | 25 | 108 | 49 | 42 |
| Profit before tax | 3.263 | 3.307 | 3.429 | 3.191 | 3.336 |
| Tax | 753 | 741 | 757 | 704 | 730 |
| Net profit | 2.510 | 2.566 | 2.673 | 2.487 | 2.606 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5.513 | 5.082 | 5.073 | 4.877 | 5.507 |
| Equity | 3.147 | 3.213 | 3.336 | 3.173 | 3.279 |
| Long-term debt | 726 | 741 | 757 | 699 | 725 |
| Short-term debt | 1.639 | 1.127 | 981 | 1.006 | 1.503 |
| Total debt | 2.365 | 1.869 | 1.737 | 1.704 | 2.228 |
EBITDA margin
58.1%
This company
15.8%
Market median
+268% vs market
20212025
Equity ratio
59.5%
This company
38.2%
Market median
+56% vs market
20212025
Return on equity
79.5%
This company
18.4%
Market median
+332% vs market
20212025
Net profit margin
45.7%
This company
8.1%
Market median
+464% vs market
20212025
Asset turnover
1.04×
This company
1.12×
Market median
+7% vs market
20212025
Debt / equity
0.68×
This company
0.62×
Market median
+10% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JM Management | Management | 2008 |
| Former (2) | ||
JF Management | Management | 2008 – 2016 |
TS Management | Management | 2016 – 2016 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2008 | |
| Company | 50–66.65% | 50–66.65% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JM BOGENSE HOLDING ApS
ØJENLÆGE JAN MØRKENBORG ApS Board members of ØJENLÆGE JAN MØRKENBORG ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Mørkenborg | Management | 0 companies |
| Jan Felix Eugen Tarnowski | Management | 0 companies |
| Thomas Storr-Paulsen | Management | 0 companies |